1. Home
  2. |Insights
  3. |CISA Releases Catalog of Cybersecurity Vulnerabilities Along With a Plan for Remediation

CISA Releases Catalog of Cybersecurity Vulnerabilities Along With a Plan for Remediation

Client Alert | 1 min read | 11.04.21

Yesterday, the Cybersecurity and Infrastructure Security Agency (CISA) released a catalog of almost 300 vulnerabilities in commonly used software known to be exploited by threat actors, along with a Binding Operational Directive (Directive or BOD) requiring Federal civilian agencies to remediate such vulnerabilities within prescribed deadlines. BOD 22-01, Reducing the Significant Risks of Known Exploited Vulnerabilities, applies to information systems operated by or for a Federal civilian agency and mandates that:

  1. Agencies review and update their internal vulnerability management procedures in accordance with the Directive by January 3, 2022;
  2. Remediate each vulnerability by the deadline set forth in the vulnerability catalog; and
  3. Report their vulnerability remediation status through CISA’s Continuous Diagnostics and Mitigation Federal Dashboard.

CISA intends to update the catalog with additional vulnerabilities once there is reliable evidence that the vulnerability has been actively exploited and there is a clear remediation action for the vulnerability, such as a vendor-provided update. Companies interested in receiving automatic updates when new vulnerabilities are added to the catalog can subscribe to the catalog update bulletin on CISA’s website.

For now, the Directive applies only to civilian agencies and contractors operating an information system on behalf of a civilian agency. It’s too soon to tell, however, whether the Department of Defense and/or the Intelligence Community will follow with similar actions. Regardless, CISA “strongly recommends” that private businesses voluntarily review the catalog, sign up to receive updates, and remediate the listed vulnerabilities in order to strengthen their cybersecurity defenses.

Contacts

Insights

Client Alert | 7 min read | 06.26.26

Federal Roundup: Updates for PBMs and Medicare Advantage Organizations

In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future....